Engineers Gate Manager LP Applied Genetic Technologies Corp Transaction History

Engineers Gate Manager LP

  • $4.86 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$3.62 - $5.23 $146,610 - $211,815
-40,500 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$3.94 - $8.19 $159,570 - $331,695
40,500 New
40,500 $205,000
Q4 2020

Feb 16, 2021
SELL
$3.99 - $5.7 $45,885 - $65,550
-11,500 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$4.38 - $6.43 $50,370 - $73,945
11,500 New
11,500 $56,000

About APPLIED GENETIC TECHNOLOGIES CORP

AGTC Quotes by TradingView
  • Ticker AGTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,632,200
  • Description
  • Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...
More about AGTC
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email